Meta-analysis: High-dose vs. low-dose metronidazole-containing therapies for Helicobacter pylori eradication treatment

Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis

(2016) Yiqiao Xin et al.   BMC GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication

(2016) Han Chen et al.   MEDICINE

Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk

(2016) J. Kälsch et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment ofHelicobacter pyloriinfection

(2015) J.-M. Liou et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans

(2015) Seiji Shiota et al.   Clinical Gastroenterology and Hepatology

In vitroantimicrobial susceptibility ofHelicobacter pylorito nine antibiotics currently used in Central Italy

(2015) Mara Di Giulio et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Helicobacter pyloriresistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria

(2015) Lyudmila Boyanova et al.   Infectious Diseases

The Evolution of Helicobacter Pylori Antibiotics Resistance Over 10 Years in Greece

(2014) Georgios P. Karamanolis et al.   DIGESTION

A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication

(2014) Jun Heo et al.   DIGESTIVE AND LIVER DISEASE

Attempts to enhance the eradication rate ofHelicobacter pyloriinfection

(2014) Chang Seok Bang   WORLD JOURNAL OF GASTROENTEROLOGY

Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection

(2014) Ala I Sharara et al.   United European Gastroenterology Journal

Pilot study: miscellaneous therapy is highly successful forHelicobacter pylorieradication

(2013) F. Sierra et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)

(2013) Alicia C Marin et al.   EXPERT OPINION ON PHARMACOTHERAPY

Antibiotic Resistance ofHelicobacter PyloriIsolated in the Southeast Coastal Region of China

(2013) Peng Su et al.   HELICOBACTER

Fourth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection

(2013) et al.   Journal of Digestive Diseases

High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates

(2012) J. Sánchez-Delgado et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Prevalence of Primary and Secondary Antimicrobial Resistance ofHelicobacter pyloriin Korea from 2003 through 2012

(2012) Jung Won Lee et al.   HELICOBACTER

Helicobacter pylorieradication therapy

(2010) Hidekazu Suzuki et al.   Future Microbiology

Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability

(2009) Jay Luther et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY